GW Pharma (GWPH) PT Raised to $164 at H.C. Wainwright
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts GWPH Hot Sheet
Price: $218.96 --0%
Rating Summary:
13 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 13 | New: 42
Rating Summary:
13 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 13 | New: 42
Join SI Premium – FREE
H.C. Wainwright analyst Douglas Tsao raised the price target on GW Pharma (NASDAQ: GWPH) to $164.00 (from $161.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Upgrades JPMorgan (JPM) to Buy, 'Greater Upside Potential'
- Elisa Oyj (ELISA:FH) (ELMUY) PT Lowered to EUR40.50 at Deutsche Bank
- Costco Wholesale (COST) PT Raised to $1,250 at Tigress Financial Partners
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
